Mark Woodard
Mark Woodard currently serves as the Business Manager for the Health & Exercise Science Department. His professional background includes experience as a research exercise physiologist and project manager on NIH-funded clinical trials; department research projects on which he has participated include the FAST, OASIS, REACT I, and REACT II studies.
Publications
Selected Publications
- Berry MJ, Woodard CM, Dunn CJ, Edwards DG, and Pittman CL. “The effects of a mountain bike suspension system on metabolic energy expenditure.” Cycling Science, 5:8, 1993.
- Berry MJ, Storsteen JA, and Woodard CM. “Effects of body mass on exercise efficiency and VO2 during steady-state cycling.” Medicine and Science in Sports and Exercise, 25(9):1031, 1993.
- Woodard CM, Berry MJ, Rejeski WJ, Ribisl PM, and Miller HS. “Exercise training in patients with cardiovascular disease and coexistent knee arthritis.” Journal of Cardiopulmonary Rehabilitation, 14(4):255, 1994.
- Woodard CM, James MK, and Messier SP. “Computational methods used in the determination of loading rate: Experimental and clinical implications.” Journal of Applied Biomechanics, 15(4):404, 1999.
- Rejeski WJ, Foley KO, Woodard CM, Zaccaro DJ, and Berry MJ. “Evaluating and understanding performance testing in COPD patients.” Journal of Cardiopulmonary Rehabilitation, 20(2):79, 2000.
- Foy CG, Rejeski WJ, Berry MJ, Zacarro D, and Woodard CM. “Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients.” Chest, 119(1):70, 2001.
- Woodard CM and Berry MJ. “Enhancing adherence to prescribed exercise: Structured behavioral interventions in clinical exercise programs”. Journal of Cardiopulmonary Rehabilitation, 21(4):201, 2001.
- Foy CG, Wickley KL, Adair N, Lang W, Miller ME, Rejeski WJ, Woodard CM, and Berry MJ. “The Reconditioning Exercise and Chronic Obstructive Pulmonary Disease Trial II (REACT II): Rationale and study design for a clinical trial of physical activity among individuals with chronic obstructive pulmonary disease”. Contemporary Clinical Trials, 27(2):135, 2006.